By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

NovImmune SA 

64 avenue de la Roseraie

Geneva    1211  Switzerland
Phone: 41-22-839-71-41 Fax: 41-22-839-71-42


SEARCH JOBS


Industry
Biotechnology

Segment
Pharmaceuticals





Company News
NovImmune SA's NI-0501 Granted Breakthrough Therapy Designation By U.S. FDA For Treatment Of Patients With Primary Hemophagocytic Lymphohistiocytosis (HLH) 3/16/2016 10:48:29 AM
NovImmune SA Completes CHF30 Million ($29.8 Million) Funding Round With Existing Shareholders 1/12/2016 12:37:56 PM
Former Roche (RHHBY) Exec Joins NovImmune SA as New CEO 12/21/2015 7:47:19 AM
NovImmune SA Abstract Selected For The "Best Of ASH" At The 2015 Annual Meeting Of American Society of Hematology (ASH) 12/16/2015 11:50:30 AM
NovImmune SA's Experimental Drug Selected For Oral Presentation At 2015 Annual Meeting Of American Society of Hematology 12/2/2015 10:11:58 AM
NovImmune SA’s Experimental Drug Selected For Oral Presentation At 2015 Annual Meeting Of American Society of Hematology 12/1/2015 10:38:38 AM
NovImmune SA Announces Presentations At 2015 American College of Rheumatology Annual Meeting 11/3/2015 12:51:52 PM
NovImmune SA's New Rheumatoid Arthritis Drug Clears Regulatory Hurdles 11/3/2015 10:37:55 AM
NovImmune SA’s New Rheumatoid Arthritis Drug Clears Regulatory Hurdles 11/2/2015 12:53:59 PM
NovImmune SA Announces Presentations At 2015 American College of Rheumatology (ACR) Annual Meeting 11/2/2015 12:51:14 PM
1234
//-->